← Eichor
Condition: Respiratory Tract Infections Rti Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Respiratory Tract Infections Rti

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT06907667Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
Phase 3 · 28 location(s) · Jena University Hospital · NCT06134492Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232Arginine Replacement Therapy in COVID-19
Phase 2 · 1 location(s) · Emory University · NCT05855330Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW)
Phase N/A · 7 location(s) · Euresist Network GEIE · NCT05534009Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06160128Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Phase N/A · 1 location(s) · Brigham and Women's Hospital · NCT01177618Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy
NA · 38 location(s) · University Hospital, Tours · NCT06966310Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )
Phase N/A · 1 location(s) · Tam Anh Research Institute · NCT07239583A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Partici
Phase 2 · 11 location(s) · SynAct Pharma Aps · NCT07633288Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
NA · 33 location(s) · Unity Health Toronto · NCT03963622Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
Phase 1 · 1 location(s) · Dalhousie University · NCT06827470Clinical Trials of Quadrivalent Influenza Vaccine
Phase 1/Phase 2 · 1 location(s) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · NCT06824519Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)
Phase N/A · 1 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT07295483A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
Phase 3 · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06174922Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Phase 1 · 1 location(s) · Stephanie B. Seminara, MD · NCT07224490Immune Defense Protein Impact On Respiratory Immune Outcomes
NA · 1 location(s) · Quantec Ltd · NCT07431840Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting
Phase 3 · 2 location(s) · Capital Medical University · NCT07236814Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
NA · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT05444946Respiratory Infections in Young Children
Phase N/A · 2 location(s) · Eduardo Lopez -Medina · NCT07249996Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)
NA · 9 location(s) · University of Bari · NCT06092554A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Phase 4 · 6 location(s) · ModernaTX, Inc. · NCT06585241First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07169318Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Phase 1/Phase 2 · 7 location(s) · Aramis Biotechnologies Inc. · NCT07291635Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
NA · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04558450Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge C
NA · 3 location(s) · Duke University · NCT06331364Effect of Implementing Evidence-based Practice and Nurse's Behavior Change on Quality of Care in Intensive Care Unit: Fo
NA · 2 location(s) · Hiroshima University · NCT06624540
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.